<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B3CB4E33-970D-4549-A873-CA578332BC98"><gtr:id>B3CB4E33-970D-4549-A873-CA578332BC98</gtr:id><gtr:name>Molplex</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B3CB4E33-970D-4549-A873-CA578332BC98"><gtr:id>B3CB4E33-970D-4549-A873-CA578332BC98</gtr:id><gtr:name>Molplex</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2228D213-85C0-471C-A9AA-40A4A4C10959"><gtr:id>2228D213-85C0-471C-A9AA-40A4A4C10959</gtr:id><gtr:firstName>Angelika</gtr:firstName><gtr:surname>Grundling</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701212"><gtr:id>E6775EF6-A8A6-4E50-8288-9A673E74A553</gtr:id><gtr:title>Conservation and biochemical characterization of the essential Staphylococcus aureus lipoteichoic acid synthase LtaS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701212</gtr:grantReference><gtr:abstractText>Lay Summary:
Staphylococcus aureus is a Gram-positive bacterial pathogen that can cause a variety of infections both in hospital settings as well as in the community. Many antibiotics, which have been successfully used to treat such bacterial infections, kill the bacterium by inhibiting the production of important surface-structures. However, an alarming aspect of staphylococcal infections is that bacteria have acquired resistance to multiple antimicrobials and the infection rate with methicillin-resistant S. aureus strains (MRSA) within the UK is amongst the highest in developed countries. Therefore, it is important to identify and validate alternative ways to inhibit staphylococcal growth. I have recently identified a protein named LtaS, which is required for the synthesis of a surface structure called lipoteichioc acid. Depletion of this protein caused a halt in lipoteichioc acid synthesis and completely blocked staphylococcal growth. These results suggest that LtaS and the lipoteichioc acid synthesis pathway can serve as targets for antibiotic development. This study aims to determine if LtaS is required for growth in other human pathogens. In addition, the proposed work will give insight into the mechanism of action of the enzyme LtaS, which will be of great benefit for the future development of lipoteichioc acid synthesis inhibitors. 

Public engagement:
Imperial College London has a dedicated press office that is responsible for the public dissemination of science through the media and with research founders and interested charities. Furthermore, the CMMI has an open-access website which is frequently updated with recent research highlights.</gtr:abstractText><gtr:technicalSummary>Staphylococcus aureus is a Gram-positive bacterial pathogen that can cause a wide variety of both community- and hospital?acquired infections. A functional cell envelope is necessary for this pathogen to interact with its environment, in particular with tissues of the infected host, and to cause infection. An important structure found within the envelope of Gram-positive bacteria is lipoteichoic acid (LTA) and I have recently identified the enzyme that is required for polyglycerolphosphate LTA synthesis. Depletion of this protein, which was renamed LtaS (for lipoteichoic acid synthase) not only led to a halt in LTA synthesis but also completely blocked staphylococcal growth. These results suggest that LtaS and the LTA synthesis pathway can serve as targets for antibiotic development, similar to the primary wall polymer peptidoglycan, which is the target of penicillin and other antibiotics. This study aims to investigate the phylogenetic distribution, structure, and enzymatic properties of LtaS. Execution of these aims will give insight into the mechanism of action of the enzyme LtaS and will be of great benefit for the development of LTA synthesis inhibitors. It is specifically proposed to:

Aim 1: Analyze the requirement of LtaS for growth and LTA synthesis in methicillin-resistant S. aureus strains and other Gram-positive pathogens
Aim 2: Investigate the role of LtaS in membrane lipid turnover
Aim 3: Determine the structure of LtaS and residues required for enzyme function</gtr:technicalSummary><gtr:fund><gtr:end>2011-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>369774</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Hannover Medical School (MHH)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Pharmacology (MHH)</gtr:department><gtr:description>cyclic nucleotide mass spec analysis</gtr:description><gtr:id>94417EF8-9663-4789-A83E-08B8208496EE</gtr:id><gtr:impact>Rebecca M. Corrigan, James C. Abbott, Heike Burhenne, Volkhard Kaever and Angelika Gr&amp;uuml;ndling (2011). Increased Intracellular c-di-AMP Levels Allow Staphylococcus aureus Growth in the Absence of Lipoteichoic Acid. PLoS Pathogens. published 01 Sep 2011 - 10.1371/journal.ppat.1002217</gtr:impact><gtr:partnerContribution>technology, data analysis and interpretationstate of the art mass spec technology; data analysis and interpretation</gtr:partnerContribution><gtr:piContribution>We started a collaboration with a lab in Germany who are expert in the analysis and quantification of nucleotides. We provided the biological question and Staphylococcus aureus expertese</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Molecular Biosciences</gtr:department><gtr:description>LtaS structure determination</gtr:description><gtr:id>026528B8-A580-4FA0-B1C6-8511BF876C1F</gtr:id><gtr:impact>Output- one publication 
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1584-9. Epub 2009 Jan 23.
Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS.
Lu D, W&amp;ouml;rmann ME, Zhang X, Schneewind O, Gr&amp;uuml;ndling A, Freemont PS.

Our group does the S. aureus biology / mutant analysis and in vitro enzyme activity analysis

Paul Freemonts group - structural part of this research</gtr:impact><gtr:partnerContribution>Structure determination</gtr:partnerContribution><gtr:piContribution>We provided the protein and in vivo and in vitro assay for the S. aureus LtaS protein</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Hannover Medical School (MHH)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Pharmacology (MHH)</gtr:department><gtr:description>cyclic nucleotide mass spec analysis</gtr:description><gtr:id>90E1C97E-0EEB-41CC-90CA-BB3AD4B7D95F</gtr:id><gtr:impact>Rebecca M. Corrigan, James C. Abbott, Heike Burhenne, Volkhard Kaever and Angelika Gr&amp;uuml;ndling (2011). Increased Intracellular c-di-AMP Levels Allow Staphylococcus aureus Growth in the Absence of Lipoteichoic Acid. PLoS Pathogens. published 01 Sep 2011 - 10.1371/journal.ppat.1002217</gtr:impact><gtr:partnerContribution>technology, data analysis and interpretationstate of the art mass spec technology; data analysis and interpretation</gtr:partnerContribution><gtr:piContribution>We started a collaboration with a lab in Germany who are expert in the analysis and quantification of nucleotides. We provided the biological question and Staphylococcus aureus expertese</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Molecular Biosciences</gtr:department><gtr:description>NMR analysis</gtr:description><gtr:id>E82DEC81-37BF-4C8A-878A-BE310CA08A8B</gtr:id><gtr:impact>Mol Microbiol. 2011 Feb;79(3):566-83. doi: 10.1111/j.1365-2958.2010.07472.x. Epub 2010 Dec 7. Enzymatic activities and functional interdependencies of Bacillus subtilis lipoteichoic acid synthesis enzymes. W&amp;ouml;rmann ME, Corrigan RM, Simpson PJ, Matthews SJ, Gr&amp;uuml;ndling A</gtr:impact><gtr:partnerContribution>state of the art NMR technology, data analysis and interpretation</gtr:partnerContribution><gtr:piContribution>We are investigation structural differences in the LTA structure in different Gram-positive bacterial strains - NMR analysis was used to do this. We provided the scientific question and knowledge in working with the gram positive pathogens</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Molplex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Molplex</gtr:description><gtr:id>9761E912-9081-4B6B-8E38-7167F345321B</gtr:id><gtr:impact>not yet applicable</gtr:impact><gtr:partnerContribution>Potential development of inhibitory compounds for this enzyme</gtr:partnerContribution><gtr:piContribution>Expertese on the structural and functional analysis of the essential Staphylococus aureus enzyme LtaS</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>News letter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>446E483A-1E03-4647-93E3-DB678F3CBE1B</gtr:id><gtr:impact>contributed towards a newsletter, news article, including a press release. Contributed towards a web site, blog or other electronic medium

could not say</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERC starter Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>E26E3E36-4344-4A59-8AD9-ED0E108CFE73</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Diverse bacterial strain were generated as part of this work. Which are catalogued and properly frozen for long term storage. We continue to use these strains in our current research</gtr:description><gtr:id>8C964179-157E-4504-856C-B1A4BCE4920D</gtr:id><gtr:impact>Supported the research of other groups.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bacterial strains</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/18DBDAEF-CEA0-4125-AA22-7D893AA0E77E"><gtr:id>18DBDAEF-CEA0-4125-AA22-7D893AA0E77E</gtr:id><gtr:title>Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes.</gtr:title><gtr:parentPublicationTitle>FEMS microbiology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/99b8c6ca130e54aa458797a84ab24ea8"><gtr:id>99b8c6ca130e54aa458797a84ab24ea8</gtr:id><gtr:otherNames>Reichmann NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0378-1097</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25D56BBF-6E6D-4365-BA0F-5E19A4A44001"><gtr:id>25D56BBF-6E6D-4365-BA0F-5E19A4A44001</gtr:id><gtr:title>Enzymatic activities and functional interdependencies of Bacillus subtilis lipoteichoic acid synthesis enzymes.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3cdc8c6bdbe8d9642b1a3d992f91c036"><gtr:id>3cdc8c6bdbe8d9642b1a3d992f91c036</gtr:id><gtr:otherNames>W?rmann ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22D96EC1-6AB1-43B5-B8C2-87D1DD0E7D3F"><gtr:id>22D96EC1-6AB1-43B5-B8C2-87D1DD0E7D3F</gtr:id><gtr:title>Two-enzyme systems for glycolipid and polyglycerolphosphate lipoteichoic acid synthesis in Listeria monocytogenes.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf1d3e43ee3bb582b85010320bd96245"><gtr:id>bf1d3e43ee3bb582b85010320bd96245</gtr:id><gtr:otherNames>Webb AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39BA37F1-739A-4D0D-91DA-871EAA53C767"><gtr:id>39BA37F1-739A-4D0D-91DA-871EAA53C767</gtr:id><gtr:title>Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b547807318acd5f0dc3ba27c7fe7636a"><gtr:id>b547807318acd5f0dc3ba27c7fe7636a</gtr:id><gtr:otherNames>Lu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3768EA7-E87E-4E78-872E-F7CC4CB06783"><gtr:id>D3768EA7-E87E-4E78-872E-F7CC4CB06783</gtr:id><gtr:title>In vitro analysis of the Staphylococcus aureus lipoteichoic acid synthase enzyme using fluorescently labeled lipids.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86b0e0055aaa7d27e761ce047e342125"><gtr:id>86b0e0055aaa7d27e761ce047e342125</gtr:id><gtr:otherNames>Karatsa-Dodgson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701212</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>